Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection
Veremis, S.A.; Maddux, M.S.; Tang, I.Y.; Millner, S.N.; Prasad, R.; Pollak, R.; Mozes, M.F.
Transplantation Proceedings 21(1 Part 2): 1476-1477
1989
ISSN/ISBN: 0041-1345 PMID: 2652473 Document Number: 329539
Document emailed within 1 workday
Related Documents
Williamson, E.P.; Millar, R.J.; Criddle, R.A.; Sells, R.A. 1987: The differentiation of acute renal allograft rejection and cyclosporine nephrotoxicity by simple urine cytology Transplantation Proceedings 19(1 Part 2): 1785-1786Toma, H.; Tanabe, K.; Oba, S.; Horita, S.; Takahashi, K.; Teraoka, S.; Ota, K. 1987: Expression of class Ii antigens in human renal allografts: comparison of acute rejection, chronic rejection, and cyclosporine nephrotoxicity Transplantation Proceedings 19(5): 3719-3720
Simić-Ogrizović, S.; Djukanović, L.; Golubović, M.; DimitrijevićZ; Mimić-Oka, J.; Simić, T. 1994: Significance of laboratory tests for differential diagnosis of acute renal allograft rejection and acute cyclosporine nephrotoxicity Srpski Arhiv Za Celokupno Lekarstvo 122(5-6): 133-136
Homan van der Heide, J.J.; Bilo, H.J.; Donker, A.J.; Wilmink, J.M.; Sluiter, W.J.; Tegzess, A.M. 1992: The effects of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients Transplantation 54(2): 257-263
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Gibbons, S.; Grevel, J.; Reynolds, K.; Ried, M.; Rutzky, L.P.; Kahan, B.D. 1988: Comparison and correlation of assays for monitoring cyclosporine drug levels in renal transplant recipients Transplantation Proceedings 20(2 Suppl 2: 339-344
Stiller, C.; Keown, P. 1990: Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy Transplantation Proceedings 22(3): 1253-1254
Zannier, A.; Mutin, M.; Touraine, J.L.; Traeger, J. 1987: Differentiation of cyclosporine A-induced nephrotoxicity from acute rejection in renal transplantation using fine-needle aspiration biopsies Transplantation Proceedings 19(5): 3630-3632
Jazzar, A.; Fagiuoli, S.; Sisson, S.; Zuhdi, N.; Cooper, D.K. 1994: Induction therapy with cyclosporine and without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients Transplantation Proceedings 26(5): 2749
McCauley, J.; Fung, J.J.; Brown, H.; Deballi, P.; Jain, A.; Todo, S.; Starzl, T.E. 1991: Renal function after conversion from cyclosporine to FK 506 in liver transplant patients Transplantation Proceedings 23(6): 3148-3149
Pabico, R.C.; Yarger, J.; Byer, B.; Kremer, M.; McKenna, B.A.; Cerilli, G.J. 1994: Effects of cyclosporine a on chronic renal transplant rejection Transplantation Proceedings 26(5): 2577-2579
Lowy, S.J.; Speiller, P.B.; Kikkawa, Y.; Hardy, M.A.; Cook, W.A. 1973: "Transplant lung" secondary to renal allograft rejection Proceedings of the Clinical Dialysis and Transplant Forum 3: 200-203
Kliem, V.; Wanner, C.; Eisenhauer, T.; Olbricht, C.J.; Doll, R.; Boddaert, M.; O'Grady, P.; Krekler, M.; Mangold, B.; Christians, U. 1996: Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine Transplantation Proceedings 28(6): 3126-3128
Nickel, P.; Lacha, J.; Ode-Hakim, S.; Sawitzki, B.; Babel, N.; Frei, U.; Volk, H.D.; Reinke, P. 2001: Cytotoxic effector molecule gene expression in acute renal allograft rejection: correlation with clinical outcome; histopathology and function of the allograft Transplantation 72(6): 1158-1160
Tredger, J.M.; Steward, C.M.; Williams, R. 1988: Blood cyclosporine concentrations in liver transplant recipients: assay method and influence of changed hepatic and renal function Transplantation Proceedings 20(3 Suppl 3: 391-393
Paul, L.C.; Chea, R.; Davidoff, A.; Benediktsson, H. 1994: Efficacy of long-term cyclosporine treatment to prevent chronic renal allograft rejection in the rat Transplantation Proceedings 26(5): 2567-2568
Troncoso, P.; Stepkowski, S.M.; Wang, M.E.; Qu, X.; Chueh, S.C.; Clark, J.; Kahan, B.D. 1999: Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine Transplantation 67(1): 145-151
MacDonald, A.S.; Daloze, P.; Dandavino, R.; Jindal, S.; Bear, L.; Dossetor, J.B.; Klassen, J.; Stiller, C.R.; Lockwood, B.; Reeve, C.E. 1987: A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Canadian Transplant Group Transplantation Proceedings 19(1 Part 3): 1865-1866
Tellis, V.A.; Matas, A.J.; Quinn, T.A.; Glicklich, D.; Weiss, R.J.; Soberman, R.J.; Veith, F.J. 1987: Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients Transplantation Proceedings 19(1 Part 3): 1892
Peng, Z.-G.; Tian, J. 2014: Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients Clinical Transplants 2014: 209-214